Drawing for M MEDEVA

USPTO serial 75485854

M MEDEVA

Reviewed by CopyMark Law Group

Reg. 2633749Status 710
Filing date
Status date
Registration date
Oct 15, 2002
Examiner
MICHOS, JOHN E
Law office
SCANNING ON DEMAND

What this means

Status 710 means the registration was cancelled because a required Section 8 declaration of continued use was not filed within the deadline (including any grace period). The federal registration is no longer active. Evaluate filing a new application if you still use the mark, or petition if cancellation was erroneous. Consult counsel on remaining common-law rights.

Status 710: Status 710 means the registration was cancelled because a required Section 8 declaration of continued use was not filed within the deadline (including any grace period). The federal registration is no longer active.

Need help with M MEDEVA?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

THOMAS J MOORE

THOMAS J MOORE BACON & THOMAS625 SLATERS LN 4TH FLALEXANDRIA, VA 22314UNITED STATES

Goods and services

ClassDescriptionStatusFirst use
005Vaccines for use in the prevention and treatment of influenza, typhoid, tetanus, pertussis, tuberculosis, cholera, rubella, yellow fever, hepatitis, polio, diphtheria, neisseria, parainfluenza, diarrheal vaccines, herpesvirus, shigella, malaria, chlamydia, syphillis, rabies, toxoplasmosis, lyme disease, human papilloma virus, dengue, encephalitis, respiratory syncytial virus, pneumococcus, streptococcus and helicobacter pylori; anaesthetics, topical anaesthetics; narcotic analgesics and analgesics; anti-hypertensives and anti-anginals; preparations for the prophylaxis and treatment of asthma; dermatological preparations; topical creams for the treatment of skin disorders; laxatives; preparations for the treatment of respiratory diseases; preparations for the treatment of sinusitis, bronchitis, pharyngitis and rhinitis; cold treatments; cough treatments; influenza treatments; expectorants, decongestants and cough suppressants; antipyretics; antihistamines; preparations for the treatment of allergies; preparations for the treatment of heart disease; anti-diarrhoea preparations; preparations for the treatment of obesity; preparations for the treatment of hyperactivity; preparations for the treatment of narcolepsy; preparations for the treatment of cancer, thrombosis and upper gastrointestinal bleeding; preparations for the treatment of gastrointestinal disorders; preparations for the treatment of edema; recombinant hormones for tissue remodelling; recombinant DNA for gene therapy of single gene disorders, corticosteroids for use in treating endocrine disorders, rheumatic disorders, dermatologic diseases, allergic states, ophthalmic diseases, respiratory diseases, hemotologic disorders, neoplastic diseases, edematous states, gastrointestinal diseases, nervous system disorders, tuberculous meningitis, tuberculosis and trichinosis; preparations for the treatment of mastocytosis; inhalers, metered dose inhalers, dry powder inhalers, pharmaceutical containers for use in inhalers, all filled with pharmaceutical preparations and substances for use in the treatment of bronchial asthma and for treating respiratory illness and disordersSECTION 8 - CANCELLED—
010Medical devices namely, injection instruments; syringes; hypodermic syringes; injectors for medical purposes; needles for medical purposes; infusion devices; inhalers; metered dose inhalers; dry powder inhalers, all of the foregoing sold emptySECTION 8 - CANCELLED—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
May 23, 2009C8..CANCELLED SEC. 8 (6-YR)—
Feb 8, 2008CFITCASE FILE IN TICRS—
Oct 15, 2002R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Jul 23, 2002PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Jul 3, 2002NPUBNOTICE OF PUBLICATION—
Apr 17, 200244EASEC. 44(E) CLAIM ADDED—
Mar 20, 2002CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Mar 20, 2002ZZZXPREVIOUS ALLOWANCE COUNT WITHDRAWN—
Mar 6, 20021.BDSec. 1(B) CLAIM DELETED—
Jan 3, 2002IUCNNOTICE OF ALLOWANCE CANCELLED—
Jul 3, 2001NOAMNOA MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
Apr 10, 2001PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Mar 28, 2001NPUBNOTICE OF PUBLICATION—
Oct 4, 2000CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Sep 20, 2000JURTJURISDICTION RESTORED TO EXAMINING ATTORNEY—
Sep 20, 2000EXPIEX PARTE APPEAL-INSTITUTED—
Feb 29, 2000CNFRFINAL REFUSAL MAILEDA final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon.
Aug 2, 1999CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Feb 1, 1999CNRTNON-FINAL ACTION MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jan 25, 1999DOCKASSIGNED TO EXAMINER—

Frequently asked questions

Related guidance